These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24586892)

  • 21. Epitope mapping of histo blood group antigens bound to norovirus VLPs using STD NMR experiments reveals fine details of molecular recognition.
    Fiege B; Leuthold M; Parra F; Dalton KP; Meloncelli PJ; Lowary TL; Peters T
    Glycoconj J; 2017 Oct; 34(5):679-689. PubMed ID: 28823097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Norovirus-host interaction: multi-selections by human histo-blood group antigens.
    Tan M; Jiang X
    Trends Microbiol; 2011 Aug; 19(8):382-8. PubMed ID: 21705222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Basis of Nanobodies Targeting the Prototype Norovirus.
    Ruoff K; Kilic T; Devant J; Koromyslova A; Ringel A; Hempelmann A; Geiss C; Graf J; Haas M; Roggenbach I; Hansman G
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of GII.4 norovirus persistence in human populations.
    Lindesmith LC; Donaldson EF; Lobue AD; Cannon JL; Zheng DP; Vinje J; Baric RS
    PLoS Med; 2008 Feb; 5(2):e31. PubMed ID: 18271619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of a surface-exposed loop facilitates trypsinization of particles of Sinsiro virus, a genogroup II.3 norovirus.
    Kumar S; Ochoa W; Kobayashi S; Reddy VS
    J Virol; 2007 Feb; 81(3):1119-28. PubMed ID: 17079293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.
    Tan M; Jiang X
    Nanomedicine (Lond); 2012 Jun; 7(6):889-97. PubMed ID: 22734641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II.
    Almanza H; Cubillos C; Angulo I; Mateos F; Castón JR; van der Poel WH; Vinje J; Bárcena J; Mena I
    J Clin Microbiol; 2008 Dec; 46(12):3971-9. PubMed ID: 18842943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genogroup IV and VI canine noroviruses interact with histo-blood group antigens.
    Caddy S; Breiman A; le Pendu J; Goodfellow I
    J Virol; 2014 Sep; 88(18):10377-91. PubMed ID: 25008923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Norovirus and histo-blood group antigens.
    Shirato H
    Jpn J Infect Dis; 2011; 64(2):95-103. PubMed ID: 21519121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.
    Sharma S; Carlsson B; Czakó R; Vene S; Haglund M; Ludvigsson J; Larson G; Hammarström L; Sosnovtsev SV; Atmar RL; Green KY; Estes MK; Svensson L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding.
    Shirato H; Ogawa S; Ito H; Sato T; Kameyama A; Narimatsu H; Xiaofan Z; Miyamura T; Wakita T; Ishii K; Takeda N
    J Virol; 2008 Nov; 82(21):10756-67. PubMed ID: 18701592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution.
    Shanker S; Choi JM; Sankaran B; Atmar RL; Estes MK; Prasad BV
    J Virol; 2011 Sep; 85(17):8635-45. PubMed ID: 21715503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Norovirus Uses Bile Salts To Escape Antibody Recognition While Enhancing Receptor Binding.
    Williams AN; Sherman MB; Smith HQ; Taube S; Pettitt BM; Wobus CE; Smith TJ
    J Virol; 2021 Jun; 95(13):e0017621. PubMed ID: 33827952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterologous expression of human norovirus GII.4 VP1 leads to assembly of T=4 virus-like particles.
    Devant JM; Hofhaus G; Bhella D; Hansman GS
    Antiviral Res; 2019 Aug; 168():175-182. PubMed ID: 31145925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of methods measuring the capsid integrity and/or functions of noroviruses by heat inactivation.
    Li D; Baert L; Xia M; Zhong W; Van Coillie E; Jiang X; Uyttendaele M
    J Virol Methods; 2012 Apr; 181(1):1-5. PubMed ID: 22266875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzymatic cleavage promotes disassembly of GII.3 norovirus virus like particles and its binding to salivary histo-blood group antigens.
    Huo Y; Wang W; Zheng L; Chen X; Shen S; Wang M
    Virus Res; 2017 Aug; 240():18-24. PubMed ID: 28754559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of probiotics on enterocyte bacterial translocation in vitro.
    Mattar AF; Drongowski RA; Coran AG; Harmon CM
    Pediatr Surg Int; 2001 May; 17(4):265-8. PubMed ID: 11409159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein.
    Tan M; Meller J; Jiang X
    J Virol; 2006 Aug; 80(15):7322-31. PubMed ID: 16840313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Noroviruses Attach to Intestinal Tissues of a Broad Range of Animal Species.
    Villabruna N; Schapendonk CME; Aron GI; Koopmans MPG; de Graaf M
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33115870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GII.4 Norovirus Protease Shows pH-Sensitive Proteolysis with a Unique Arg-His Pairing in the Catalytic Site.
    Viskovska MA; Zhao B; Shanker S; Choi JM; Deng L; Song Y; Palzkill T; Hu L; Estes MK; Venkataram Prasad BV
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.